A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia.
Times cited: 2
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 17
- Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): A randomised open-label phase 2 study. The Lancet Oncology. 2013 Academic Article GET IT
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
Times cited: 177